All In MedTech

FDA Clearance Tracker · P000037

ON-X (R) PROSTHETIC HEART VALVE, MODEL ONXA

Premarket approval (PMA) is the pathway for the highest-risk devices. FDA reviews clinical evidence of safety and effectiveness before approving.

Last checked: Nov 20, 2026Latest source record: May 30, 2001 (this decision)Source: openFDAMethods & limitations

PMA

Decided

May 30, 2001

Approved

Time to decision

271 days

Received Sep 1, 2000. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA

Device class

Class III

The decision

FDA number
P000037
Device name
ON-X (R) PROSTHETIC HEART VALVE, MODEL ONXA
Applicant location
Kennesaw, GA
Received
Sep 1, 2000
Decided
May 30, 2001
Decision
Approved
Supplements
65 in FDA's data for this PMA. See them on the FDA record

Device type

Device class
Class III

Every decision under product code LWQ

FDA's approval statement

As written in FDA's record.

APPROVAL FOR THE ON-X. PROSTHETIC HEART VALVE, MODEL ONXA IN THE AORTIC POSITION INCLUDING SIZES 19, 21, 23, 25, AND 27/29 MM. THIS DEVICE IS INDICATED FOR REPLACEMENT OF DISEASED, DAMAGED, OR MALFUNCTIONING NATIVE OR PROSTHETIC HEART VALVES IN THE AORTIC POSITION.

How new is this?

These are facts about FDA's records. They are not a judgment about the device.

  • It is not the first decision under product code LWQ. The earliest in FDA's data is P790018, decided Dec 23, 1981.
  • It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.

Source documents

Other decisions for On-X Life Technologies, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

No other decisions since 2015 under this exact applicant name.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.